Tag: backs

Posted on

FDA panel backs Glaxo asthma drug for adults, not adolescents – Reuters


Channel News Asia

FDA panel backs Glaxo asthma drug for adults, not adolescents
Reuters
The panel voted 16 to 4 that the product, Breo Ellipta, should be approved for once daily treatment of asthma in adults 18 years and older. It voted 19 to 1 that the data did not support approval for use in children aged 12 to 17. The FDA is not …
Critical inspection of GlaxoSmithKline plc (ADR) (NYSE:GSK) by FDA …WallStreet.org
FDA panel backs Glaxo inhaler for adults, not adolescentsTown Hall
GSK and Theravance Announce Outcome of US FDA Advisory Committee on …MarketWatch
Healio
all 12 news articles »

View full post on asthma – Google News

Posted on

NICE backs FeNO devices for asthma diagnosis – Nursing Times


Gloucestershire Echo

NICE backs FeNO devices for asthma diagnosis
Nursing Times
It has recommended three devices – NIOX MINO, NIOX VERO and NObreath – to measure the levels of fractional-exhaled nitric oxide (FeNO) a patient is breathing out that are indicative of inflammation associated with asthma. The institute's guidance …
Asthma sufferers recommended breath test pioneered in GloucestershireGloucestershire Echo
Search for jobs in the North EastThe Journal

all 3 news articles »

View full post on asthma – Google News

Posted on

UK health cost body backs Novartis asthma drug in fresh U-turn – Chicago Tribune

UK health cost body backs Novartis asthma drug in fresh U-turn
Chicago Tribune
LONDON (Reuters) – Britain's health cost-effectiveness watchdog NICE said it planned to recommend the use of Novartis's severe asthma drug Xolair after prevaricating for months over whether it should be paid for on the taxpayer-funded National Health …
Life-changing jab gives hope to asthma sufferersExpress.co.uk
Asthma treatment – double U-turnWebMD.Boots.com
NICE U-turn on Novartis' Xolair for asthmaPharmaTimes
OnMedica –The Daily Telegraph –GP online
all 10 news articles »

View full post on asthma – Google News

Posted on

UK health cost body backs Novartis asthma drug in fresh U-turn – Yahoo! News (blog)


Yahoo! News (blog)

UK health cost body backs Novartis asthma drug in fresh U-turn
Yahoo! News (blog)
LONDON (Reuters) – Britain's health cost-effectiveness watchdog NICE said it planned to recommend the use of Novartis's severe asthma drug Xolair after prevaricating for months over whether it should be paid for on the taxpayer-funded National Health …
U-turn As Asthma Drug Gets Go-aheadThe Australian
NICE U-turn over asthma drug omalizumabGP online

all 3 news articles »

View full post on asthma – Google News

Posted on

UK health cost body backs Novartis asthma drug in fresh U-turn – Reuters

UK health cost body backs Novartis asthma drug in fresh U-turn
Reuters
LONDON (Reuters) – Britain's health cost-effectiveness watchdog NICE said it planned to recommend the use of Novartis's severe asthma drug Xolair after prevaricating for months over whether it should be paid for on the taxpayer-funded National Health …
NICE U-turn over asthma drug omalizumabGP online

all 2 news articles »

View full post on asthma – Google News

Posted on

Burgess backs temporary rescue for asthma inhalers – Fort Worth Star Telegram


Fort Worth Star Telegram

Burgess backs temporary rescue for asthma inhalers
Fort Worth Star Telegram
That's why he filed a bill that recently passed a House subcommittee to let over-the-counter emergency asthma inhalers — pulled from the shelves at the beginning of this year — still be sold in pharmacies, even if that's just until they sell out. "I …

View full post on asthma – Google News